LINK Medical has announced the integration of Pharm Assist into the LINK Medical family.
“We are very excited to have Pharm Assist integrate with our network of expert teams, especially strengthening our already robust regulatory group making us very unique in our industry. Our Regulatory team across the Nordics now has over 60 specialists, including more than 15 in Sweden. The integration enables LINK Medical to provide strong and comprehensive support for Biotech, MedTech, and Pharma companies in need of a strategic partner. Companies have the flexibility of working with us from concept to market, for stand-alone support on marketed products or outsourced when needed,” says Sissel Lønning Andresen, CEO at LINK Medical.
Pharm Assist is a consultant and service company based in Uppsala offering regulatory solutions for Medicinal and MedTech products since 1996. The Pharm Assist team will continue to services in Regulatory Affairs, Pharmacovigilance, Medical Writing, and Good Distribution Practice (GDP) to national and international companies as part of the wider LINK Medical group, states LINK Medical in a press release.
Acquired in May 2022 by the Life Science Service Group
Pharm Assist was acquired in May 2022 by the Life Science Service Group, established by Serendipity Partners, who also own LINK Medical.
As the integration is now being finalized, customers will benefit from an extended pool of knowledgeable experts as well as a wider range of services, from early-phase development to post-marketing, states LINK Medical.
“LSSG is a great home for Pharm Assist as we share the same company values and strategic vision as Serendipity and LINK Medical. Our clients will get personal links to our consultants through both a larger geographic footprint and service offering in the Nordics and northern Europe,” says Dr. Mats Ehrnebo, founder and owner of Pharm Assist.